1887

Abstract

Urinary tract infections (UTIs) caused by uropathogenic (UPEC) are amongst the most common bacterial infectious diseases in the developed world. The urovirulence of UPEC is mainly associated with the surface-exposed fimbrial adhesins and adhesins of the autotransporter (AT) family. The best studied of these proteins is antigen Ag43 mediating cell aggregation, adhesion and biofilm development as the causes of chronic UTIs. The IH11128 Dr ( ) strain of the Dr/Afa family of adhesins possesses two major surface-exposed virulence factors: Dr fimbrial polyadhesin and DraD protein (fimbrial tip subunit or protein component of the adhesive sheath). Here, we identified for the first time, to our knowledge, the gene encoding Ag43 in the WT clinical isolate of UPEC Dr as a new virulence factor not yet tested. We also found that Dr fimbrial expression, which like Ag43 is under the control of a phase-variable mechanism, did not exclude Ag43 surface presentation. However, the presence of Dr fimbriae supported by other structures on the cell surface caused a physical neutralization of Ag43-mediated autoaggregation during growth. The fimbrial bundling further increased the distance between the adjacent Ag43 cells, thus preventing head-to-tail association between surface-exposed Ag43 subunits and their interactions with the host cells. The investigations showed that Ag43 did not act as a specific adhesin and invasin, conversely to the major virulence factors of Dr, but played significant roles in the viability and metabolic activity of bacterial cells forming biofilm, and in the survival of bacteria within invaded epithelial cells.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.000072
2015-05-01
2020-04-08
Loading full text...

Full text loading...

/deliver/fulltext/micro/161/5/1034.html?itemId=/content/journal/micro/10.1099/mic.0.000072&mimeType=html&fmt=ahah

References

  1. Adam B., Baillie G. S., Douglas L. J.. 2002; Mixed species biofilms of Candida albicans and Staphylococcus epidermidis . J Med Microbiol51:344–349 Medline
    [Google Scholar]
  2. Anderson G. G., Palermo J. J., Schilling J. D., Roth R., Heuser J., Hultgren S. J.. 2003; Intracellular bacterial biofilm-like pods in urinary tract infections. Science301:105–107doi:10.1126/science.1084550 Medline[CrossRef]
    [Google Scholar]
  3. Anderson K. L., Billington J., Pettigrew D., Cota E., Simpson P., Roversi P., Chen H. A., Urvil P., du Merle L., Barlow P. N.. 2004; An atomic resolution model for assembly, architecture, and function of the Dr adhesins. Mol Cell15:647–657doi:10.1016/j.molcel.2004.08.003 Medline[CrossRef]
    [Google Scholar]
  4. Blattner F. R., Plunkett G. III, Bloch C. A., Perna N. T., Burland V., Riley M., Collado-Vides J., Glasner J. D., Rode C. K., other authors. 1997; The complete genome sequence of Escherichia coli K-12. Science277:1453–1462doi:10.1126/science.277.5331.1453 Medline[CrossRef]
    [Google Scholar]
  5. Blomfield I. C., McClain M. S., Princ J. A., Calie P. J., Eisenstein B. I.. 1991; Type 1 fimbriation and fimE mutants of Escherichia coli K-12. J Bacteriol173:5298–5307 Medline
    [Google Scholar]
  6. Caffrey P., Owen P.. 1989; Purification and N-terminal sequence of the alpha subunit of antigen 43, a unique protein complex associated with the outer membrane of Escherichia coli . J Bacteriol171:3634–3640 Medline
    [Google Scholar]
  7. Celik N., Webb C. T., Leyton D. L., Holt K. E., Heinz E., Gorrell R., Kwok T., Naderer T., Strugnell R. A., other authors. 2012; A bioinformatic strategy for the detection, classification and analysis of bacterial autotransporters. PLoS One7:e43245doi:10.1371/journal.pone.0043245 Medline[CrossRef]
    [Google Scholar]
  8. Chen S. L., Hung C. S., Xu J., Reigstad C. S., Magrini V., Sabo A., Blasiar D., Bieri T., Meyer R. R., other authors. 2006; Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc Natl Acad Sci U S A103:5977–5982doi:10.1073/pnas.0600938103 Medline[CrossRef]
    [Google Scholar]
  9. Cota E., Jones C., Simpson P., Altroff H., Anderson K. L., du Merle L., Guignot J., Servin A., Le Bouguénec C., other authors. 2006; The solution structure of the invasive tip complex from Afa/Dr fibrils. Mol Microbiol62:356–366doi:10.1111/j.1365-2958.2006.05375.x Medline[CrossRef]
    [Google Scholar]
  10. Danese P. N., Pratt L. A., Dove S. L., Kolter R.. 2000; The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol37:424–432doi:10.1046/j.1365-2958.2000.02008.x Medline[CrossRef]
    [Google Scholar]
  11. Diderichsen B.. 1980; flu, a metastable gene controlling surface properties of Escherichia coli . J Bacteriol141:858–867 Medline
    [Google Scholar]
  12. Eto D. S., Sundsbak J. L., Mulvey M. A.. 2006; Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli . Cell Microbiol8:704–717doi:10.1111/j.1462-5822.2006.00691.x Medline[CrossRef]
    [Google Scholar]
  13. Fang L., Nowicki B., Yallampalli C.. 2001; Differential expression of uterine NO in pregnant and nonpregnant rats with intrauterine bacterial infection. Am J Physiol Regul Integr Comp Physiol280:R1356–R1363 Medline
    [Google Scholar]
  14. Foxman B.. 1990; Recurring urinary tract infection: incidence and risk factors. Am J Public Health80:331–333doi:10.2105/AJPH.80.3.331 Medline[CrossRef]
    [Google Scholar]
  15. Foxman B.. 2002; Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med113:Suppl 1A5–13doi:10.1016/S0002-9343(02)01054-9 Medline[CrossRef]
    [Google Scholar]
  16. Foxman B., Brown P.. 2003; Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am17:227–241doi:10.1016/S0891-5520(03)00005-9 Medline[CrossRef]
    [Google Scholar]
  17. Foxman B., Zhang L., Tallman P., Palin K., Rode C., Bloch C., Gillespie B., Marrs C. F.. 1995; Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. J Infect Dis172:1536–1541doi:10.1093/infdis/172.6.1536 Medline[CrossRef]
    [Google Scholar]
  18. Frazier C. L., San Filippo J., Lambowitz A. M., Mills D. A.. 2003; Genetic manipulation of Lactococcus lactis by using targeted group II introns: generation of stable insertions without selection. Appl Environ Microbiol69:1121–1128doi:10.1128/AEM.69.2.1121-1128.2003 Medline[CrossRef]
    [Google Scholar]
  19. Gabrielson J., Hart M., Jarelöv A., Kühn I., McKenzie D., Möllby R.. 2002; Evaluation of redox indicators and the use of digital scanners and spectrophotometer for quantification of microbial growth in microplates. J Microbiol Methods50:63–73doi:10.1016/S0167-7012(02)00011-8 Medline[CrossRef]
    [Google Scholar]
  20. Garcia M. I., Jouve M., Nataro J. P., Gounon P., Le Bouguénec C.. 2000; Characterization of the AfaD-like family of invasins encoded by pathogenic Escherichia coli associated with intestinal and extra-intestinal infections. FEBS Lett479:111–117doi:10.1016/S0014-5793(00)01898-6 Medline[CrossRef]
    [Google Scholar]
  21. Goluszko P., Popov V., Selvarangan R., Nowicki S., Pham T., Nowicki B. J.. 1997a; Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. J Infect Dis176:158–167doi:10.1086/514018 Medline[CrossRef]
    [Google Scholar]
  22. Goluszko P., Moseley S. L., Truong L. D., Kaul A., Williford J. R., Selvarangan R., Nowicki S., Nowicki B. J.. 1997b; Development of experimental model of chronic pyelonephritis with Escherichia coli O75 : K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J Clin Invest99:1662–1672doi:10.1172/JCI119329 Medline[CrossRef]
    [Google Scholar]
  23. Goluszko P., Niesel D., Nowicki B., Selvarangan R., Nowicki S., Hart A., Pawelczyk E., Das M., Urvil P., Hasan R.. 2001; Dr operon-associated invasiveness of Escherichia coli from pregnant patients with pyelonephritis. Infect Immun69:4678–4680doi:10.1128/IAI.69.7.4678-4680.2001 Medline[CrossRef]
    [Google Scholar]
  24. Hasman H., Chakraborty T., Klemm P.. 1999; Antigen-43-mediated autoaggregation of Escherichia coli is blocked by fimbriation. J Bacteriol181:4834–4841 Medline
    [Google Scholar]
  25. Henderson I. R., Nataro J. P.. 2001; Virulence functions of autotransporter proteins. Infect Immun69:1231–1243doi:10.1128/IAI.69.3.1231-1243.2001 Medline[CrossRef]
    [Google Scholar]
  26. Henderson I. R., Meehan M., Owen P.. 1997; Antigen 43, a phase-variable bipartite outer membrane protein, determines colony morphology and autoaggregation in Escherichia coli K-12. FEMS Microbiol Lett149:115–120doi:10.1111/j.1574-6968.1997.tb10317.x Medline[CrossRef]
    [Google Scholar]
  27. Henderson I. R., Cappello R., Nataro J. P.. 2000; Autotransporter proteins, evolution and redefining protein secretion. Trends Microbiol8:529–532doi:10.1016/S0966-842X(00)01853-9 Medline[CrossRef]
    [Google Scholar]
  28. Henderson I. R., Navarro-Garcia F., Desvaux M., Fernandez R. C., Ala'Aldeen D.. 2004; Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev68:692–744doi:10.1128/MMBR.68.4.692-744.2004 Medline[CrossRef]
    [Google Scholar]
  29. Johnson J. R.. 1991; Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev4:80–128 Medline
    [Google Scholar]
  30. Jouve M., Garcia M. I., Courcoux P., Labigne A., Gounon P., Le Bouguénec C.. 1997; Adhesion to and invasion of HeLa cells by pathogenic Escherichia coli carrying the afa-3 gene cluster are mediated by the AfaE and AfaD proteins, respectively. Infect Immun65:4082–4089 Medline
    [Google Scholar]
  31. Justice S. S., Hung C., Theriot J. A., Fletcher D. A., Anderson G. G., Footer M. J., Hultgren S. J.. 2004; Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A101:1333–1338doi:10.1073/pnas.0308125100 Medline[CrossRef]
    [Google Scholar]
  32. Kajava A. V., Steven A. C.. 2006; The turn of the screw: variations of the abundant beta-solenoid motif in passenger domains of Type V secretory proteins. J Struct Biol155:306–315doi:10.1016/j.jsb.2006.01.015 Medline[CrossRef]
    [Google Scholar]
  33. Kajava A. V., Cheng N., Cleaver R., Kessel M., Simon M. N., Willery E., Jacob-Dubuisson F., Locht C., Steven A. C.. 2001; Beta-helix model for the filamentous haemagglutinin adhesin of Bordetella pertussis and related bacterial secretory proteins. Mol Microbiol42:279–292doi:10.1046/j.1365-2958.2001.02598.x Medline[CrossRef]
    [Google Scholar]
  34. Klemm P., Schembri M. A.. 2000; Bacterial adhesins: function and structure. Int J Med Microbiol290:27–35doi:10.1016/S1438-4221(00)80102-2 Medline[CrossRef]
    [Google Scholar]
  35. Klemm P., Hjerrild L., Gjermansen M., Schembri M. A.. 2004; Structure-function analysis of the self-recognizing Antigen 43 autotransporter protein from Escherichia coli . Mol Microbiol51:283–296doi:10.1046/j.1365-2958.2003.03833.x Medline[CrossRef]
    [Google Scholar]
  36. Le Bouguénec C., Servin A. L.. 2006; Diffusely adherent Escherichia coli strains expressing Afa/Dr adhesins (Afa/Dr DAEC): hitherto unrecognized pathogens. FEMS Microbiol Lett256:185–194doi:10.1111/j.1574-6968.2006.00144.x Medline[CrossRef]
    [Google Scholar]
  37. McCluskey C., Quinn J. P., McGrath J. W.. 2005; An evaluation of three new-generation tetrazolium salts for the measurement of respiratory activity in activated sludge microorganisms. Microb Ecol49:379–387doi:10.1007/s00248-004-0012-z Medline[CrossRef]
    [Google Scholar]
  38. Mobley H. L., Green D. M., Trifillis A. L., Johnson D. E., Chippendale G. R., Lockatell C. V., Jones B. D., Warren J. W.. 1990; Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun58:1281–1289 Medline
    [Google Scholar]
  39. Mulvey M. A., Schilling J. D., Hultgren S. J.. 2001; Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun69:4572–4579doi:10.1128/IAI.69.7.4572-4579.2001 Medline[CrossRef]
    [Google Scholar]
  40. Mysorekar I. U., Hultgren S. J.. 2006; Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A103:14170–14175doi:10.1073/pnas.0602136103 Medline[CrossRef]
    [Google Scholar]
  41. Nowicki B., Barrish J. P., Korhonen T., Hull R. A., Hull S. I.. 1987; Molecular cloning of the Escherichia coli O75X adhesin. Infect Immun55:3168–3173 Medline
    [Google Scholar]
  42. Nowicki B., Truong L., Moulds J., Hull R.. 1988; Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. Am J Pathol133:1–4 Medline
    [Google Scholar]
  43. Nowicki B., Svanborg-Edén C., Hull R., Hull S.. 1989; Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli . Infect Immun57:446–451 Medline
    [Google Scholar]
  44. Nowicki B., Fang L., Singhal J., Nowicki S., Yallampalli C.. 1997; Lethal outcome of uterine infection in pregnant but not in nonpregnant rats and increased death rate with inhibition of nitric oxide. Am J Reprod Immunol38:309–312doi:10.1111/j.1600-0897.1997.tb00521.x Medline[CrossRef]
    [Google Scholar]
  45. Nowicki B., Singhal J., Fang L., Nowicki S., Yallampalli C.. 1999; Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice. Infect Immun67:2421–2427 Medline
    [Google Scholar]
  46. Nowicki B., Selvarangan R., Nowicki S.. 2001; Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. J Infect Dis183:Suppl 1S24–S27doi:10.1086/318846 Medline[CrossRef]
    [Google Scholar]
  47. Oelschlaeger T. A., Dobrindt U., Hacker J.. 2002; Pathogenicity islands of uropathogenic E. coli and the evolution of virulence. Int J Antimicrob Agents19:517–521doi:10.1016/S0924-8579(02)00092-4 Medline[CrossRef]
    [Google Scholar]
  48. Owen P., Kaback H. R.. 1978; Molecular structure of membrane vesicles from Escherichia coli . Proc Natl Acad Sci U S A75:3148–3152doi:10.1073/pnas.75.7.3148 Medline[CrossRef]
    [Google Scholar]
  49. Owen P., Meehan M., de Loughry-Doherty H., Henderson I.. 1996; Phase-variable outer membrane proteins in Escherichia coli . FEMS Immunol Med Microbiol16:63–76doi:10.1111/j.1574-695X.1996.tb00124.x Medline[CrossRef]
    [Google Scholar]
  50. Perutka J., Wang W., Goerlitz D., Lambowitz A. M.. 2004; Use of computer-designed group II introns to disrupt Escherichia coli DExH/D-box protein and DNA helicase genes. J Mol Biol336:421–439doi:10.1016/j.jmb.2003.12.009 Medline[CrossRef]
    [Google Scholar]
  51. Pettit R. K., Weber C. A., Kean M. J., Hoffmann H., Pettit G. R., Tan R., Franks K. S., Horton M. L.. 2005; Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother49:2612–2617doi:10.1128/AAC.49.7.2612-2617.2005 Medline[CrossRef]
    [Google Scholar]
  52. Pia˛tek R., Zalewska B., Kolaj O., Ferens M., Nowicki B., Kur J.. 2005; Molecular aspects of biogenesis of Escherichia coli Dr fimbriae: characterization of DraB–DraE complexes. Infect Immun73:135–145doi:10.1128/IAI.73.1.135-145.2005 Medline[CrossRef]
    [Google Scholar]
  53. Plançon L., Du Merle L., Le Friec S., Gounon P., Jouve M., Guignot J., Servin A., Le Bouguénec C.. 2003; Recognition of the cellular beta1-chain integrin by the bacterial AfaD invasin is implicated in the internalization of afa-expressing pathogenic Escherichia coli strains. Cell Microbiol5:681–693doi:10.1046/j.1462-5822.2003.00308.x Medline[CrossRef]
    [Google Scholar]
  54. Rana T., Hasan R. J., Nowicki S., Venkatarajan M. S., Singh R., Urvil P. T., Popov V., Braun W. A., Popik W., other authors. 2014; Complement protective epitopes and CD55–microtubule complexes facilitate the invasion and intracellular persistence of uropathogenic Escherichia coli . J Infect Dis209:1066–1076doi:10.1093/infdis/jit619 Medline[CrossRef]
    [Google Scholar]
  55. Schembri M. A., Klemm P.. 2001; Coordinate gene regulation by fimbriae-induced signal transduction. EMBO J20:3074–3081doi:10.1093/emboj/20.12.3074 Medline[CrossRef]
    [Google Scholar]
  56. Schembri M. A., Kjaergaard K., Klemm P.. 2003; Global gene expression in Escherichia coli biofilms. Mol Microbiol48:253–267doi:10.1046/j.1365-2958.2003.03432.x Medline[CrossRef]
    [Google Scholar]
  57. Servin A. L.. 2005; Pathogenesis of Afa/Dr diffusely adhering Escherichia coli . Clin Microbiol Rev18:264–292doi:10.1128/CMR.18.2.264-292.2005 Medline[CrossRef]
    [Google Scholar]
  58. Sherlock O., Schembri M. A., Reisner A., Klemm P.. 2004; Novel roles for the AIDA adhesin from diarrheagenic Escherichia coli: cell aggregation and biofilm formation. J Bacteriol186:8058–8065doi:10.1128/JB.186.23.8058-8065.2004 Medline[CrossRef]
    [Google Scholar]
  59. Ulett G. C., Valle J., Beloin C., Sherlock O., Ghigo J. M., Schembri M. A.. 2007; Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun75:3233–3244doi:10.1128/IAI.01952-06 Medline[CrossRef]
    [Google Scholar]
  60. van der Woude M. W., Henderson I. R.. 2008; Regulation and function of Ag43 (flu). Annu Rev Microbiol62:153–169doi:10.1146/annurev.micro.62.081307.162938 Medline[CrossRef]
    [Google Scholar]
  61. van der Woude M. W., Braaten B. A., Low D. A.. 1992; Evidence for global regulatory control of pilus expression in Escherichia coli by Lrp and DNA methylation: model building based on analysis of pap . Mol Microbiol6:2429–2435doi:10.1111/j.1365-2958.1992.tb01418.x Medline[CrossRef]
    [Google Scholar]
  62. Van Loy C. P., Sokurenko E. V., Moseley S. L.. 2002; The major structural subunits of Dr and fig1845 fimbriae are adhesins. Infect Immun70:1694–1702doi:10.1128/IAI.70.4.1694-1702.2002 Medline[CrossRef]
    [Google Scholar]
  63. Welch R. A., Burland V., Plunkett G. III, Redford P., Roesch P., Rasko D., Buckles E. L., Liou S. R., Boutin A., other authors. 2002; Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli . Proc Natl Acad Sci U S A99:17020–17024doi:10.1073/pnas.252529799 Medline[CrossRef]
    [Google Scholar]
  64. Wells T. J., Totsika M., Schembri M. A.. 2010; Autotransporters of Escherichia coli: a sequence-based characterization. Microbiology156:2459–2469doi:10.1099/mic.0.039024-0 Medline[CrossRef]
    [Google Scholar]
  65. Wróblewska-Seniuk K., Selvarangan R., Hart A., Pladzyk R., Goluszko P., Jafari A., duMerle L., Nowicki S., Yallampalli C., other authors. 2005; Dra/AfaE adhesin of uropathogenic Dr/Afa+ Escherichia coli mediates mortality in pregnant rats. Infect Immun73:7597–7601doi:10.1128/IAI.73.11.7597-7601.2005 Medline[CrossRef]
    [Google Scholar]
  66. Wróblewska-Seniuk K., Nowicki S., Le Bouguénec C., Nowicki B., Yallampalli C.. 2011; Maternal/fetal mortality and fetal growth restriction: role of nitric oxide and virulence factors in intrauterine infection in rats. Am J Obstet Gynecol205:83e1–83e7doi:10.1016/j.ajog.2011.02.049 Medline[CrossRef]
    [Google Scholar]
  67. Zalewska B., Pia˛tek R., Konopa G., Nowicki B., Nowicki S., Kur J.. 2003; Chimeric Dr fimbriae with a herpes simplex virus type 1 epitope as a model for a recombinant vaccine. Infect Immun71:5505–5513doi:10.1128/IAI.71.10.5505-5513.2003 Medline[CrossRef]
    [Google Scholar]
  68. Zalewska B., Pia˛tek R., Bury K., Samet A., Nowicki B., Nowicki S., Kur J.. 2005; A surface-exposed DraD protein of uropathogenic Escherichia coli bearing Dr fimbriae may be expressed and secreted independently from DraC usher and DraE adhesin. Microbiology151:2477–2486doi:10.1099/mic.0.28083-0 Medline[CrossRef]
    [Google Scholar]
  69. Zalewska-Pia˛tek B., Bury K., Pia˛tek R., Bruździak P., Kur J.. 2008; Type II secretory pathway for surface secretion of DraD invasin from the uropathogenic Escherichia coli Dr+ strain. J Bacteriol190:5044–5056doi:10.1128/JB.00224-08 Medline[CrossRef]
    [Google Scholar]
  70. Zalewska-Pia˛tek B. M., Wilkanowicz S. I., Pia˛tek R. J., Kur J. W.. 2009; Biofilm formation as a virulence determinant of uropathogenic Escherichia coli Dr+ strains. Pol J Microbiol58:223–229 Medline
    [Google Scholar]
  71. Zalewska-Pia˛tek B., Wilkanowicz S., Bruździak P., Pia˛tek R., Kur J.. 2013; Biochemical characteristic of biofilm of uropathogenic Escherichia coli Dr+ strains. Microbiol Res168:367–378doi:10.1016/j.micres.2013.01.001 Medline[CrossRef]
    [Google Scholar]
  72. Zhong J., Karberg M., Lambowitz A. M.. 2003; Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker. Nucleic Acids Res31:1656–1664doi:10.1093/nar/gkg248 Medline[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.000072
Loading
/content/journal/micro/10.1099/mic.0.000072
Loading

Data & Media loading...

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error